Supernus Pharmaceuticals | Crediti Commerciali



Trade Debtors Cambiamento Data
Abbott USD 6.93B 126M 2024-12
ANI Pharmaceuticals USD 221.73M 19.26M 2024-12
Aurora Cannabis CAD 49.52M 9.36M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Canopy Growth CAD 49.06M 7.2M 2024-12
Corcept Therapeutics USD 53.98M 5.74M 2024-12
Eisai JPY 235.64B 40.42B 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Indivior 288M 17M 2024-12
Novo Nordisk 79.63B 3.5B 2024-09
Pacira USD 113.3M 12.65M 2024-12
Perrigo USD 686.2M 99.7M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12
United Therapeutics USD 279.3M 62.5M 2024-12
Xeris Pharmaceuticals USD 40.42M 723K 2024-12



Supernus Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.